Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates
There is still plenty of reason to worry about unproven stem cells being marketed in the U.S. and elsewhere around the world. I’ll start with a new item here in the U.S. on a firm called MD Stem Cells and end with a newly published paper about how things are going in Poland on this […]
Weekly reads: MD Stem Cells, embryo models & headaches, cell therapy trial updates Read More »